STUDIES AND GRANTS

• Evaluation of the efficacy and safety of CT 102 (APST) in the treatment of chronic, non-healing,
  Cutaneous wounds in patients with diabetes mellitus:  A multicenter, randomized, double-blind,placebo-controlled study.  Protocol study 208.  Principal investigator:  Norman H. Rappaport, D.D.S., M.D.  Co-investigator:  David T. Netscher, M.D.  A study funded by Curative Technologies, Inc.  In affiliation with The Methodist Hospital, Baylor College of Medicine and the Veteran’s Administration Medical Center, Houston, Texas.
• Evaluation of the efficacy and safety of autologous platelet derived wound healing factors
  (APDWHF) delivered via a collagen sponge in the treatment of chronic non- healing venous stasis wounds:  A multicenter open-labeled pilot study.  Protocol 107.
  Principal investigator: Norman H. Rappaport, D.D.S., M.D.  Co- investigator:  David T. Netscher, M.D.  A study funded by Curative Technologies, Inc.  In affiliation with Baylor College of Medicine and the Veteran’s Hospital, Houston, Texas.
• Evaluation of a wide variety of physical injuries with fluorescent dye.   Grant received 1979. Baylor College of Medicine
• Evaluation of the effects of cigarette smoking and transdermal delivery of nicotine on digital
  Perfusion.  Principal investigator:  David T. Netscher, M.D.  Co-investigator:  Norman H. Rappaport, D.D.S., M.D.  A study funded by Lederle Laboratories, Pearl River, New York, in affiliation with Baylor College of Medicine and the Veteran’s Administration Hospital, Houston, Texas.